vWf levels as a circulating marker of endothelial dysfunction in patients with hypertrophic cardiomyopathy

Indian Heart J. 2005 Nov-Dec;57(6):655-7.

Abstract

Background: The aim of the present study was to investigate whether the von Willebrand factor levels, as a possible indicator of endothelial dysfunction, is increased in hypertrophic cardiomyopathy, and also whether it is related to the clinical status of hypertrophic cardiomyopathy.

Methods and results: The study group comprised 29 patients with hypertrophic cardiomyopathy and 29 healthy age- and gender-matched control subjects. There was no significant difference in von Willebrand factor levels between study group (77.0 +/- 23.1%) and control group (88.5 +/- 34.2%). There was no statistically significant difference between control group (88.5 +/- 34.2%) and functional class I/II group (82.0 +/- 24.3%), between control group and functional class III group (67.6 +/- 18.3%) and between functional class I/II group and functional class III group with respect to the von Willebrand factor levels.

Conclusions: The results suggest that von Willebrand factor levels, as a possible indicator of endothelial dysfunction, are not increased in patients with hypertrophic cardiomyopathy and von Willebrand factor levels are not related to functional class in these patients.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Biomarkers / analysis
  • Biomarkers / blood
  • Cardiomyopathy, Dilated / blood
  • Cardiomyopathy, Dilated / diagnosis*
  • Case-Control Studies
  • Endothelium, Vascular / pathology*
  • Endothelium, Vascular / physiopathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Probability
  • Prognosis
  • Prospective Studies
  • Reference Values
  • Risk Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index
  • von Willebrand Factor / analysis*

Substances

  • Biomarkers
  • von Willebrand Factor